We also found that the achieved Ca, P and PTH levels were not optimal; even the management of CKD-MBD in China was based on the Kidney Disease: Improving Global Outcomes (KDIGO) guideline10. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.